Analyst Ratings for OncoCyte Corp (OCX) [Neutrals]
OCX Rating Summary
OCX Price Target Summary
- Highest: $5.00 (Benchmark)
- Lowest: $4.25 (Needham)
- Average: $4.63
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$4.63 (+88%)
* Over Last 12-Mos
Rating Score: 3.3 / 10
Percentile Rank: 30%
Rating Score: 3.3 / 10
Percentile Rank: 30%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/1/2022 | Lake Street Capital Markets | Thomas Flaten | Downgrade | Hold (Buy) |
0.50 (N/A) |
0.47 (2.46) |
423.4% | Details |
| 12/1/2022 | BTIG | Mark A. Massaro | Downgrade | Neutral (Buy) |
N/A (N/A) |
0.47 (2.46) |
423.4% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
